New scan could spare throat cancer patients from unnecessary radiation side effects

NCT ID NCT07241273

Not yet recruiting Disease control Sponsor: UNICANCER Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 22, 2026 · Updated 2 times

Summary

This study tests whether a special scan (SPECT-CT) can show which side of the neck needs radiation in people with oropharyngeal cancer. Currently, both sides are treated to prevent hidden cancer spread, but this causes more side effects. The trial will enroll 128 patients to see if using the scan to treat only one side keeps cancer from coming back while improving quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

head and neck cancer Head and Neck Neoplasms oropharyngeal carcinoma oropharynx cancer oropharynx squamous cell carcinoma Squamous Cell Carcinoma of Head and Neck

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEAD AND NECK HEAD AND NECK CANCER HEAD AND NECK CANCERS OROPHARYNGEAL CANCERS OROPHARYNGEAL CARCINOMA OROPHARYNGEAL SQUAMOUS CELL CARCINOMA

Contacts and locations

Locations

CHRU Tours - Hôpital Bretonneau

Tours, France
CHU Brest

Brest, France
CHU Caen

Caen, France
Centre François Baclesse

Caen, France
Centre Georges François Leclerc

Dijon, France
Centre Henri Becquerel

Rouen, France
Centre Oscar Lambret

Lille, France
Centre de Radiothérapie Guillaume Le Conquérant

Le Havre, France
Hôpital Tenon

Paris, France
Hôpitaux Universitaires de Strasbourg - Hôpital de Hautepierre

Strasbourg, France
Institut Régional du Cancer de Montpellier

Montpellier, France
Institut de Cancérologie Strasbourg Europe

Strasbourg, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.